metricas
covid
Buscar en
Gastroenterología y Hepatología (English Edition)
Toda la web
Inicio Gastroenterología y Hepatología (English Edition) Chronic diarrhea: The first symptom of a metastatic medullary thyroid carcinoma
Journal Information
Vol. 41. Issue 2.
Pages 105-107 (February 2018)
Vol. 41. Issue 2.
Pages 105-107 (February 2018)
Scientific letter
Full text access
Chronic diarrhea: The first symptom of a metastatic medullary thyroid carcinoma
Diarrea crónica: el primer síntoma de un carcinoma medular de tiroides metastásico
Visits
5280
Ander Ernaga Loreaa,
Corresponding author
andernaga@hotmail.es

Corresponding author.
, Iranzu Migueliz Bermejob, Nerea Eguílaz Esparzaa, María Cecilia Hernández Morhaina, Javier Pineda Arribasa
a Complejo Hospitalario de Navarra, Pamplona, Navarra, Spain
b Centro de Salud de San Jorge, Pamplona, Navarra, Spain
This item has received
Article information
Full Text
Bibliography
Download PDF
Statistics
Figures (1)
Tables (1)
Table 1. Causes of chronic diarrhoea according to pathogenesis.
Full Text

Chronic diarrhoea (lasting for more than 4–6 weeks) is relatively common among the general population. The main causes according to pathogenesis are shown in Table 1. It is essential to take a detailed medical history and perform a thorough physical examination to adequately manage this disorder, since this makes it possible to screen for patients requiring more detailed tests and examinations.

Table 1.

Causes of chronic diarrhoea according to pathogenesis.

Osmotic diarrhoea 
Osmotic laxatives 
Carbohydrate malabsorption 
Excessive ingestion of poorly absorbed carbohydrates 
Lactulose, sorbitol, mannitol, fructose, fibre 
 
Secretory diarrhoea 
Congenital chloride diarrhoea 
Bacterial enterotoxins 
Inflammatory bowel disease 
Crohn's disease, ulcerative colitis, microscopic colitis (collagenous or lymphocytic) 
Vasculitis 
Drugs 
Non-osmotic laxatives, antibiotics 
Food allergies 
Heavy metal poisoning 
Bacterial overgrowth 
Neoplasms 
Colorectal cancer, lymphoma, villous adenoma 
Endocrinological causes 
Tumours (carcinoid, gastrinoma, somatostatinoma, medullary thyroid carcinoma, VIPoma) 
Systemic (adrenal insufficiency, hyperthyroidism) 
Bile acid malabsorption 
Ileal resection, post-cholecystectomy, idiopathic 
Non-invasive infections 
Giardiasis, cryptosporidiosis 
Amyloidosis 
Idiopathic secretory diarrhoea 
 
Steatorrhoea 
Maldigestion 
Decreased secretion of bile acids (cirrhosis, biliary obstruction, ileal resection) 
Pancreatic insufficiency (chronic pancreatitis, cystic fibrosis, pancreatic duct blockage) 
Malabsorption 
Coeliac disease 
Giardiasis 
Whipple's disease 
Chronic mesenteric ischaemia 
Short bowel syndrome 
Bacterial overgrowth (diabetes, scleroderma, history of bowel surgery) 
Lymphatic obstruction 
 
Inflammatory diarrhoea 
Inflammatory bowel disease 
Crohn's disease, ulcerative colitis, microscopic colitis, diverticulitis 
Neoplasms 
Colorectal cancer, lymphoma 
Radiation colitis/enteritis 
Mastocytosis 
Bacterial infections 
Clostridium difficile, Shigella, Salmonella, Campylobacter, Yersinia 
Viral infections 
Cytomegalovirus, herpes simplex virus 
Parasites 
Amoebiasis, strongyloidiasis 
Ischaemic colitis 
 
Diarrhoea due to motility disorders 
Post-operative (post-vagotomy or post-sympathectomy) 
Scleroderma 
Diabetic autonomic neuropathy 
Hyperthyroidism 
Irritable bowel syndrome 
Faecal impaction 
Faecal incontinence 

This article looks at the case of a 36-year-old male with no notable medical history who started with diarrhoea with 3–4 stools a day, some during the night, without blood, mucus or pus. He had no abdominal pain, nausea, vomiting or fever. His symptoms were not related to meal times, and he showed no improvement, despite a lactose-free diet. On physical examination, his abdomen was soft, non-tender and with no palpable masses or organomegaly.

A full blood count and stool culture were ordered, both of which were within the normal ranges. Due to the persistence of symptoms for 4 months and the presence of nocturnal bowel movements, the patient was assessed by the digestive diseases department. A colonoscopy and endoscopy were ordered, revealing only the presence of erosive gastritis; the patient was found to be Helicobacter pylori positive. The patient took antibiotic treatment for H. pylori eradication, but symptoms persisted.

A broader study was ordered including an abdominal ultrasound. Numerous nodular hyperechoic liver lesions were observed that are compatible with metastasis. Therefore, a CT scan of the chest and abdomen was performed. The CT scan showed the same liver nodules, osteoblastic bone lesions and a thyroid nodule, all of which is indicative of a neuroendocrine tumour (Fig. 1).

Figure 1.

Coronal section of an abdominal CT scan showing the presence of liver metastases.

(0.13MB).

More blood tests, including tumour marker tests, were ordered, showing very high calcitonin (38,653ng/l, normal range 0–18.2) and carcinoembryonic antigen levels (1065ng/ml, normal range 0–5.4). For better characterisation of the thyroid nodule, an ultrasound of the neck was performed which showed a lesion in the left thyroid lobe measuring 37mm with ultrasound characteristics of malignancy. It also showed the presence of multiple swollen lymph nodes in the central, ipsilateral and contralateral compartments of the neck.

A biopsy of this nodule and one of the lymph nodes was compatible with medullary thyroid carcinoma (MTC) and, therefore, RET proto-oncogene mutation and urinary catecholamine and metanephrine tests were ordered due to the possibility of pheochromocytoma in the event of multiple endocrine neoplasia. The genetic study revealed a heterozygous RET mutation at pC618R. Urinary catecholamines and metanephrines were normal, which ruled out the concomitant presence of pheochromocytoma.

In view of these results, it was decided to perform a total thyroidectomy and removal of lymph nodes from the neck in order to prevent local symptoms and facilitate future treatments. Histological examination confirmed multifocal, bilateral MTC with vascular and lymphatic invasion.

After being assessed by the oncology department, it was decided to complete treatment with tyrosine kinase inhibitors.

Twelve months after surgery, tumour markers have remained stable, and the disease has not progressed in imaging studies.

For the initial management of chronic diarrhoea, it is essential to look for warning signs or symptoms, such as blood in the stool, fever, weight loss, family history of cancer, nocturnal diarrhoea or diarrhoea that persists even during fasting or hepatosplenomegaly.1

Neuroendocrine tumours account for less than 1% of causes of chronic diarrhoea, and, therefore, do not tend to be considered during initial screening. It may therefore be several years before a diagnosis is reached.2 MTC is a neuroendocrine tumour that originates from the C cells or parafollicular cells of the thyroid gland and accounts for 1–2% of all thyroid cancers.3 Although diarrhoea is a relatively common symptom of MTC, it does not tend to be the first manifestation of the tumour since the appearance of a mass in the neck is the most common symptom. The mechanism that causes diarrhoea is fundamentally fluid and electrolyte secretion, induced by various peptides (calcitonin, serotonin, VIP),2,4 although there may also be an increase in intestinal motility.

Initial screening tests for these tumours include an ultrasound of the neck.5 The most sensitive diagnostic test is the cytologic smear using a fine-needle aspiration biopsy with positive staining for calcitonin, chromogranin A and carcinoembryonic antigen.6 Plasma calcitonin and carcinoembryonic antigen levels are useful for diagnosing and monitoring this type of tumour.7 Calcitonin, although not a specific marker, also correlates with the extent of the disease.8

In 75% of cases, MTC is sporadic, while in 25% of cases it is hereditary. It is generally associated with multiple endocrine neoplasia and hereditary MTC due to RET proto-oncogene mutation. This mutation should be studied in all patients diagnosed with this type of tumour, and appropriate genetic counselling should be provided.9,10

This is an interesting case because chronic diarrhoea was the patient's only symptom, but a diagnosis of metastatic MTC was reached. A detailed medical history and a thorough physical examination are essential to determine which patients require complementary examinations and tests.

References
[1]
P.D. Thomas, A. Forbes, J. Green, P. Howdle, R. Long, R. Playford, et al.
Guidelines for the investigation of chronic diarrhoea, 2nd edition.
Gut, 52 (2003), pp. 1-15
[2]
R.T. Jensen.
Overview of chronic diarrhea caused by functional neuroendocrine neoplasms.
Semin Gastrointest Dis, 10 (1999), pp. 156-172
[3]
S.A. Wells Jr., S.L. Asa, H. Dralle, R. Elisei, D.B. Evans, R.F. Gagel, et al.
Revised American Thyroid Association Guidelines for the management of medullary thyroid carcinoma.
Thyroid, 25 (2015), pp. 567-610
[4]
F.W.F. Hanna, J.E.S. Ardill, C.F. Johnston, R.T. Cunningham, W.J. Curry, C.F.J. Russell, et al.
Regulatory peptides and other neuroendocrine markers in medullary carcinoma of the thyroid.
J Endocrinol, 152 (1997), pp. 275-281
[5]
M.A. Kouvaraki, S.E. Shapiro, B.D. Fornage, B.S. Edeiken-Monro, S.I. Sherman, R. Vassilopoulou-Sellin, et al.
Role of preoperative ultrasonography in the surgical management of patients with thyroid cancer.
Surgery, 134 (2003), pp. 946-954
[6]
P. Trimboli, G. Treglia, L. Guidobaldi, F. Romanelli, G. Nigri, S. Valabrega, et al.
Detection rate of FNA cytology in medullary thyroid carcinoma: a meta-analysis.
Clin Endocrinol (Oxf), 82 (2015), pp. 280-285
[7]
G. Costante, C. Durante, Z. Francis, M. Schlumberger, S. Filetti.
Determination of calcitonin levels in C-cell disease: clinical interest and potential pitfalls.
Nat Clin Pract Endocrinol Metab, 5 (2009), pp. 35-44
[8]
A. Machens, H. Dralle.
Biomarker-based risk stratification for previously untreated medullary thyroid cancer.
J Clin Endocrinol Metab, 95 (2010), pp. 2655-2663
[9]
C.J. Lips, J.W. Hoppener, B.P. van Nesselrooij, R.B. van der Luijt.
Counselling in multiple endocrine neoplasia syndromes: from individual experience to general guidelines.
J Intern Med, 257 (2005), pp. 69-77
[10]
L.M. Mulligan, J.B.J. Kwok, C.S. Healey, M.J. Elsdon, C. Eng, E. Gardner, et al.
Germ-line mutations of the RET protooncogene in multiple endocrine neoplasia type-2A.
Nature, 363 (1993), pp. 458-460

Please cite this article as: Ernaga Lorea A, Migueliz Bermejo I, Eguílaz Esparza N, Hernández Morhain MC, Pineda Arribas J. Diarrea crónica: el primer síntoma de un carcinoma medular de tiroides metastásico. Gastroenterol Hepatol. 2018;41:105–107.

Copyright © 2017. Elsevier España, S.L.U.. All rights reserved
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos